Elle was the first patient accrued to the Duke-initiated "Mountaineer" study, a clinical trial for CRC patients with a HER2 amplification. She was a trailblazer. It worked. Here is HERstory and the HIStory behind her oncologist's novel approach.

Seagen Inc. announced positive topline results last month of a pivotal phase 2 clinical trial (called MOUNTAINEER) of a novel drug combination for HER2-positive metastatic colorectal cancer. DCI led the trial and enrolled the trial's first patient.

“It was a great trip, but when I got off the boat, I couldn’t regain my ‘land legs,’” said Lisa VanTress, then 55. Days later a trip to the ER after a fall revealed a shocking diagnosis — two brain tumors. Lung cancer.

Charles Riggan, 68, (pictured above with clinical trial nurse coordinator Quinna Lawson) is well-known on the clinic floor for the Werther’s Original caramels he passes out during almost-weekly visits to Duke Cancer Center.

For some patients, targeted therapy is their best shot. The Molecular Tumor Board at DCI is matching more and more patients to approved therapies and clinical trials.

Nadine is a long way from her childhood home of Toronto, a long way from the Bahamas where she first met Fay in 1968, & a very long way from New Zealand where they vacationed in 2014 and where she noticed “some fairly large lumps” behind her ear.

About a thousand people and 50 plus dogs rose early on Saturday morning, March 24, to attend an unseasonably cold CRUSH Colorectal Cancer 5K and Fun Walk. The spring freeze couldn’t crush their team spirit. 45 teams raised more than $81,000.

The 2017 CRUSH Colorectal Cancer 5K and Fun Walk, attracted more than 1,000 participants and raised a record $102,273 and counting — breaking last year’s record.

Duke Fencing students are asking the community to Fence4TheFight against breast cancer, in honor of their long-time manager Elizabeth Beguinet.

Gerard Blobe, MD, PhD, and Jingfan (Jean) Huang discuss her progress on a Phase 1 treatment trial she matched to at Duke for advanced bile duct cancer. (Oct. 1, 2019)

“What I’m looking for as I hire these new nurses is someone who’s coming out enthusiastic to learn; someone who’s compassionate and empathetic and a real go-getter," said nurse manager Joey Misuraca, RN. Randy Amoako, BSN, RN, was one of those hires.

Tom Dinwiddie, 69, was featured in the Journal of Gastrointestinal Cancer four years ago for having survived 30 months past an end-stage cancer diagnosis. He’s now lived nearly six years with no evidence of recurrent or metastatic disease. Just after…

The sky was clear. The sun was bright. And Angie Vega and her husband Dave Izquierdo were in high spirits. Right up near the stage at the American Cancer Society’s Making Strides Against Breast Cancer walk, they were animated and sociable.

Every fall, Wesley Brandt fires up the charcoal smoker in his backyard to make turkey barbecue. But this year he’s not sure if he’ll have the stamina. That’s because Brandt, 65, is fighting breast cancer.

On an icy day in January a diverse group of female veterans – eight in all – braved the elements to attend the Durham Veterans Affairs Medical Center (VAMC) for the hospital’s first-ever Breast Cancer Support Group gathering.

For a fourth year, Duke Cancer Institute teamed up with the American Cancer Society to serve as local presenting sponsor at the charity’s Making Strides Against Breast Cancer walk held in Raleigh on Oct. 14.

Since completing treatment for lung cancer nearly seven years ago, Bob Wienberry, 80, has been volunteering in the thoracic oncology clinic at Duke Cancer Institute.

Bright sunshine-y skies and cool temps greeted the sea of pink patients, survivors and supporters that flooded Midtown Park at North Hills starting at dawn — the hurricane two days before already a distant memory.